Introduction
Developmental dysplasia of the hip (DDH) is the most common hip disorder in children.1-3 The incidence varies from 1 to 34/1000 births depending on different diagnostic standards and methods. Furthermore, the prevalence in Central Europe and Asia is higher in comparison with African countries.4-6 Recognized risk factors for DDH are: 1) breech position; 2) family history; 3) oligohydramnion; 4) female gender; 5) firstborn; and 6) presence of musculoskeletal diseases e.g. club foot.5,7,8 A genetic influence is currently discussed.9
Clinical as well as ultrasound examinations are proven methods for early diagnosis.10-12 In several European countries the ultrasound examination according to Graf is part of the ‘well-baby-program’ or used as selective diagnostic tool. According to Graf, the ultrasound findings are basic for classification and allow differentiation between stable but immature and dysplastic hip types (I–II stable) and unstable hip types (D, III, IV).13
Stable hips are regularly controlled by clinical and ultrasound examination and/or treated with various splints e.g. the Tübingen splint.14 In the treatment of unstable hips, plaster of Paris (POP) in human position e.g. the Fettweis POP or splints e.g. the Pavlik harness, have been proven successful as treatment tools.15-18 Under certain conditions unstable hips can be successfully treated with the Tübingen splint.19,20.All therapies are based on the principle: 1) reduction; 2) retention; and 3) maturation.
The Fettweis POP – which is used in the present study – was developed in 1968.15 The application is carried out under short anesthesia. Prior to the application of the plaster the concentric reduction and safe position, normally in 90° to 100° flexion and 40° to 50° abduction, can be checked by arthrography. In more severe cases (especially in hip type IV), previous treatment with overhead extension for about two to three weeks may become indicated.21 After plaster application the corrected hip position is checked by various imaging procedures e.g. MRI examination.22,23 Following the treatment with the Fettweis POP, further therapy with various splints or bandages is necessary until a transfer into a clinical and ultrasound stable hip type I is achieved.
Standard anterior-posterior pelvic radiograph controls can be indicated from the age of six months. From this age on, ultrasound imaging is more difficult due to increased ossification of the cartilaginous precursors.24-26 However, in many protocols radiograph controls are not conducted under the age of 12 months in order to reduce exposure to radiation.
For evaluation of radiograph controls various lines and angles are used (Fig. 1). Here the acetabular (AC) angle is a parameter used to evaluate DDH. The AC angle is measured along the Hilgenreiner line and the AC roof. Based on these findings, the classification and evaluation of DDH according to Tönnis is established. With consideration of age, gender and affected side the Tönnis classification distinguishes between normal findings (< 1 sd), slightly dysplastic (1 sd to 2 sd) and severely dysplastic (> 2 sd) hips.2,27
Fig. 1 Pelvic radiograph of a two-year-old girl: (a) horizontal line = Hilgenreiner Line; (b) vertical line = Perkins lines; (c) line below the left femoral neck = Shenton Menard line; acetabular angle left (*) and centre edge angle right hip (#), time point: 28 June 2010.
The formerly valid thesis that a ‘normal’ hip after successful treatment does not deteriorate with growth is more and more called into question and regular radiograph controls are recommended until cessation of growth. In this study we therefore examined the course of unstable hips which were successfully treated with Fettweis POP with respect to the initial ultrasound hip type and age at diagnosis and treatment.
Patients and materials
Patients
From November 2001 to April 2015, 104 consecutive children with 132 unstable hip joints were treated with the Fettweis plaster at our institution. The treatment protocol is shown in Fig. 2.
Fig. 2 Treatment protocol of unstable hips type D, III and IV with Fettweis plaster.
Inclusion criteria for this retrospective study were 1) unstable hip according to Graf that were successfully transferred into an ultrasound stable hip type I by treatment with the Fettweis POP followed by treatment with the Tübingen splint; and 2) presence of routine pelvic radiograph controls at the age of 12 to 24 months and 24 to 48 months.
Children with secondary hip dysplasia, e.g. infantile cerebral palsy, spina bifida or other neurological diseases, were excluded.
Methods
Classification and evaluation of the hip joints was based on routine pelvic radiograph controls at the age of 12 to 24 months and 24 to 48 months of children after successful treatment with the Fettweis plaster and afterwards with the Tübingen splint until transfer into an ultrasound stable hip type I is reached. Evaluation focused on: 1) initial ultrasound hip type according to Graf; 2) average age at first and second radiograph control; and 3) determination of the AC-index according to the Tönnis classification2 and evaluation into: normal findings (< 1 sd), slightly dysplastic findings (1 sd to 2 sd) and severely dysplastic findings (> 2 sd).
Further avascular necrosis of the femoral head (AVN) was classified according to Kalamchi and MacEwen into type I to IV.28
All measurements were performed by two different physicians (HK and JPH) who were blinded to the patients’ diagnosis.
Statistical analysis
Results are presented as mean ± SEM using SPSS Statistics Version 23 (IBM Corp., Armonk, New York).
Results
In all, 75 children with 93 unstable hip joints (18 bilateral) were included. There were 14 (15.1%) hips with initial hip type D, 41 (44.1%) with hip type III and 38 (40.9%) with hip type IV. In all, 63/75 (84%) of the children were female.
Radiograph results of all patients
The first routine pelvic radiograph was conducted at a mean age of 13.9 months (sd 2.7, 9 to 22, n = 93) and the second radiographic control was conducted at a mean of 28.5 months (sd 6.1, 21 to 48, n = 93).
In comparison between the first and second time point, 22/36 hips (61.1%) with normal findings showed constant normal findings, 9/36 hips (25.0%) deteriorated into slightly dysplastic hips and 5/36 into severely dysplastic hips (13.9%). Overall, 9/34 of formerly slightly dysplastic hips (26.5%) improved into normal findings, 17/34 stayed slightly dysplastic (50.0%) and 8/34 deteriorated into severe dysplasia (23.5%). Overall, 17/23 of previous severely dysplastic findings (73.9%) showed constant severe dysplasia, 2/23 improved to normal findings (8.7%) and 4/23 to slight dysplasia (17.4%) (Fig. 3). A total of 15/93 hips (16.1%) improved, whereas 22/93 hips (23.7%) deteriorated (Table 1).
Fig. 3 Comparison of 12 to 24 months versus 24 to 48 months, n = 93, improvement of nine slightly dysplastic hips and two severely dysplastic hips into normal findings, four severely dysplastic hips into slightly dysplastic hips, deterioration of nine normal findings into slightly dysplastic hips and five severely dysplastic hips, eight slightly dysplastic hips into severely dysplastic hips.
Same level | Improvement | Deterioration | |
All hips (n = 93) (%) | 56 (60.0) | 15 (16.1) | 22 (23.7) |
Treatment ≤ 8 wks (n = 16) (%) | 10 (62.5) | 4 (25.0) | 2 (12.5) |
Treatment > 8 wks (n = 77) (%) | 46 (59.7) | 11 (14.3) | 20 (26.0) |
Table 1 Comparison first versus second radiograph based on start of treatment (all hips (n = 93), treatment at eight or less weeks of age (n = 16) and more than eight weeks of age (n = 77)).
Radiograph results of patients with start of treatment at age eight or less weeks
According to IBM SPSS Statistics Version 23, the turning point from which improvement of the hips could be observed was calculated at eight weeks of age.
In 16 cases (hip type D: 1, III: 7, IV: 8) the treatment with Fettweis plaster started eight or less weeks of age. The mean age was 39.7 days (sd 9.1, 23 to 54).
The first pelvic radiograph was taken at a mean age of 14.0 months (sd 2.3, 12 to 22), the second radiograph was conducted at a mean of 29.1 months (sd 6.8, 24 to 48). In comparison with pelvic radiograph controls in the second year of life versus 24 to 48 months, there was total increase of normal findings of 33.3%. Overall, 6/6 hips (100%) with normal findings showed constant normal findings, 1/6 slightly (16.7%) and 1/4 severely dysplastic hip (25.0%) improved into normal findings. A decrease of 16.7% of slight dysplasia was seen. Here 3/6 were still slightly dysplastic (50.0%). Overall, 1/6 hips (16.7%) improved into normal findings and 2/6 hips (33.3%) deteriorated into severe dysplasia (hip type III and IV). Overall 1/4 hips (25.0%) with severe dysplasia showed constant severely dysplastic findings. Overall, 2/4 (50.0%) improved into slightly dysplastic findings and 1/4 (25.0%) into normal findings (total decrease of severe dysplasia of 25%) (Fig. 4). Here, a total of 4/16 hips (25.0%) improved, whereas 2/16 hips (12.5%) deteriorated (Table 1).
Fig. 4 Comparison of 12 to 24 months versus 24 to 48 months, n = 16, improvement of one slightly dysplastic hip and one severely dysplastic hip into normal findings, two severely dysplastic hips into slightly dysplastic hips, deterioration of two slightly dysplastic hips into severely dysplastic hips.
Radiograph results of patients with start of treatment at more than eight weeks of age
There were 77 unstable hips (hip type D: 13, III: 34, IV: 30) which were treated with Fettweis POP after the eighth week of life. Mean age was 115.7 days (sd 58.4, 57 to 331).
The first radiograph control was conducted at a mean age of 13.8 months (sd 2.8, 9 to 20) and the second control was at a mean age of 28.3 months (sd 5.9, 21 to 48).
In comparison of the two time points a decrease of normal findings of 16.7% were seen. Here 16/30 hips (53.3%) with normal findings in the first control showed constant normal findings, 9/30 (30.0%) deteriorated into slight dysplasia and 5/30 (16.7%) into severe dysplasia. The number of slightly dysplastic hips was decreased by 10.7%. Overall, 8/28 hips (28.6%) improved into normal findings, 14/28 (50.0%) showed constant slight dysplasia and 6/28 (21.4%) deteriorated into severely dysplastic hips. A total increase of 42.1% of severely dysplastic hips was seen. Here 16/19 hips (84.2%) were constantly severely dysplastic, 2/19 (10.5%) improved into slight dysplasia and 1/19 into normal findings (5.3%) (Fig. 5). A total of 11/77 hips (14.3%) improved, whereas 20/77 hips (26.0%) deteriorated (Table 1).
Fig. 5 Comparison of 12 to 24 months versus 24 to 48 months, n = 77, improvement of eight slightly dysplastic hips and one severely dysplastic hip into normal findings, two severely dysplastic hips into slightly dysplastic hips, deterioration of nine normal findings into slightly dysplastic hips and five severely dysplastic hips, six slightly dysplastic hips into severely dysplastic hips.
Radiograph results in relation to initial ultrasound hip type
Our data show that the radiological development of all hips is independent of the initial ultrasound hip type at diagnosis and despite a successful transfer into an ultrasound hip type I.
Initial hip type D (n = 14): 5/7 normal findings (71.4%), show constant normal findings, but 2/7 deteriorated into slight dysplasia (28.6%). Overall, 2/7 slightly dysplastic hips improved into normal findings (28.6%), 2/7 were constantly slightly dysplastic (28.6%) and 3/7 slightly deteriorated into severe dysplasia (42.9%) (Figs 6a and 7, Table 2).
Fig. 6 Comparison of 12 to 24 months versus 24 to 48 months: (a) hip type D: n = 14, improvement of two slightly dysplastic hips into normal findings, deterioration of two normal findings into slightly dysplastic hips, three slightly dysplastic hips into severely dysplastic hips; (b) hip type III: n = 41, improvement of five slightly dysplastic hips and one severely dysplastic hip into normal findings, two severely dysplastic hips into slightly dysplastic hips, deterioration of four normal findings into slightly dysplastic hips and one severely dysplastic hip, three slightly dysplastic hips into severely dysplastic hips; (c) hip type IV: n = 38, improvement of two slightly dysplastic hips and one severely dysplastic hip into normal findings, two severely dysplastic hips into slightly dysplastic hips, deterioration of three normal findings into slightly dysplastic hips and four severely dysplastic hips, two slightly dysplastic hips into severely dysplastic hips.
Fig. 7 (a) Pelvic radiograph of a 15-month-old child (initial ultrasound hip type D right and type IV left) with acetabular angle right: 27.9° (1 sd to 2 sd) and left: 31.4° (2 sd), time point 19 August 2013; (b) pelvic radiograph of the same child at 25 months of age with: acetabular angle right: 27.6° (2 sd) and left: 36.3° (2 sd), operative intervention for both sides recommended, time point 16 June 2014.
Same level | Improvement | Deterioration | |
Type D (n = 14) (%) | 7 (50.0) | 2 (14.3) | 5 (35.7) |
Type III (n = 41) (%) | 25 (61.0) | 8 (19.5) | 8 (19.5) |
Type IV (n = 38) (%) | 24 (63.2) | 5 (13.2) | 9 (23.7) |
Table 2 Comparison first versus second radiograph based on initial hip type (type D (n = 14), type III (n = 41), type IV (n = 38))
Initial hip type III (n = 41): 8/13 of normal findings were constant normal (61.5%), 4/13 deteriorated into slight dysplasia (23.1%) and 1/13 into severe dysplasia (7.7%), 5/18 of slightly dysplastic hips improved into normal findings (27.8%), 10/18 were constantly slightly dysplastic (55.6%) and 3/18 deteriorated into severely dysplastic hips (16.7%). Overall, 1/10 initial severely dysplastic hips improved into normal findings (10.0%), 2/10 into slight dysplasia (20.0%) and 7/10 showed constant severe dysplasia (70.0%) (Fig. 6b, Table 2).
Initial hip type IV (n = 38): 9/16 show constant normal findings (56.3%), 3/16 deteriorated into slight (18.8%) and 4/16 into severe dysplasia (25.0%). Overall, 2/9 slightly dysplastic findings improved into normal findings (22.2%), 5/9 were constantly slightly dysplastic (55.6%), 2/9 deteriorated into severe dysplasia (22.2%). Overall, 1/13 severely dysplastic findings improved into normal findings (7.7%) and 2/13 into slight dysplasia (15.4%). Overall, 10/13 were constant severely dysplastic (76.9%) (Fig. 6c, Table 2).
AVN of the femoral head
AVN type I and II according to the Kalamchi and MacEwen types were seen in five cases (5.4%) (hip type III: 2, IV: 3).
Operative interventions
In eight hips (8.6%) an operative correction (Salter osteotomy) was conducted after the second radiograph control (hip type III: 4, IV: 4) and in another 13 cases (14.0%) a surgical intervention was recommended (hip type D: 1, III: 7, IV: 5).
The exact information on the results can be found in Table 3.
First radiograph | Second radiograph | |
Normal findings (%) | 36 (38.7) (D: 50.0%, III: 31.7%, IV: 42.1%) | 33 (35.5) (D: 50.0%, III: 34.2%, IV: 26.3%) |
Slight dysplasia (%) | 34 (36.6) (D: 50.0%, III: 43.9%, IV: 23.7%) | 9 (32.2) (D: 28.6%, III: 39.0%, IV: 26.3%) |
Severe dysplasia (%) | 23 (24.7) (D: 0%, III: 24.4%, IV: 34.2%) | 30 (32.3) (D: 21.4%, III: 26.8%, IV:42.1%) |
Radiograph results of patients with start of treatment ≤ 8 wks of age (n = 16) | ||
Normal findings(%) | 6 (37.5) (D: 100.0%, III: 42.9%, IV: 25.0%) | 8 (50.0) (D: 100.0%, III: 57.1%, IV: 37.5%) |
Slight dysplasia (%) | 6 (37.5) (III: 57.1%, IV: 25.0%) | 5 (31.3) (III: 28.6%, IV: 37.5%) |
Severe dysplasia (%) | 4 (25.0) (IV: 50.0%) | 3 (18.6) (type III: 14.3%, IV: 25%) |
Radiograph results of patients with start of treatment > 8 wks of age (n = 77) | ||
Normal findings(%) | 30 (38.9) (D: 46.2%, III: 29.4%, IV: 46.7%) | 25 (32.5) (D: 46.2%, III: 29.4%, IV: 30.0%) |
Slight dysplasia (%) | 28 (36.4) (D: 53.8%, III: 41.2%, IV: 23.3%) | 25 (32.5) (D: 30.8%, III: 41.2%, IV: 23.3%) |
Severe dysplasia (%) | 19 (24.7) (III: 29.4%, IV: 30.0%) | 27 (35.1) (D: 23.1%, III: 29.4%, IV: 46.7%) |
Table 3 Radiograph results of all patients (n = 93)
Discussion
For early detection and classification of DDH general screening methods including ultrasound examinations are accepted and well established in European countries 11,29. However, in some Anglo-American countries an ultrasound examination is only performed in children with risk factors such as breech position or family history. Here the opponents of general ultrasound screening discuss exaggerated diagnostics.30-32 However, both – Anglo-Americans and Europeans – have consensus that early diagnosis and treatment are crucial to prevent progression of the dysplasia and lead to beneficial outcome for the children. Our data confirm this hypothesis. To the best of our knowledge, this is the first study that examined in detail the development of initially unstable hips treated with Fettweis POP with respect to initial ultrasound hip type and age. Our results clearly show that start of treatment with reduction of the hip and retention in the Fettweis POP at age eight weeks or less show better outcome with increase of normal findings and decrease of slightly respectively severely dysplastic findings in comparison with the results with start of treatment at more than eight weeks of age. Here, the radiological results deteriorate after the first radiograph control in all classifications according to Tönnis although an ultrasound hip type I has been achieved after treatment with Fettweis plaster and afterwards with the Tübingen splint. Our results confirm other studies, which show deteriorating findings after treatment with other treatment modalities, e.g. Pavlik harness.33-35 We support the conclusion that regular controls are recommended until cessation of growth.
Interestingly, the radiograph results show that the unpredictable development with, on one hand improvement and on the other hand, deterioration of hips, is independent of the initial ultrasound hip type at diagnosis and independent of successful transfer into an ultrasound hip type I. Even hips with initial hip type D deteriorated into severely dysplastic hips. This further indicates that regular radiograph controls seem to be mandatory to detect deterioration over time and need to be early enough to indicate and perform operative improvement of AC orientation. These findings support those of other studies which use other treatment modalities e.g. Pavlik harness or Tübingen Splint and recommend further radiograph controls as well.25,36-39 However, so far, there is no standard algorithm for control examinations after successfully treated DDH.6 Some authors also recommend other control examinations such as ultrasound and CT.40,41
Our examinations show a total of 5.4% AVN after the second radiograph control. These findings are confirmed by other studies that have also a low rate of AVN after treatment with Fettweis POP.42,43 In contrast, other treatment modalities, e.g. Pavlik harness, show a slightly higher rate of AVN.35,44,45 Comparisons between the different studies are known to be limited because of diagnostic criterias, e.g. study groups with different age at diagnosis, age at beginning of treatment, different classification and different control time points.
Limitations of our study include the fact that it was a non-randomized trial and the small number of the group with treatment starting at eight or less weeks of age (n = 16).
We demonstrate for the first time, that radiograph controls after successful treatment of unstable hips with Fettweis plaster with transfer into an ultrasound stable hip show poorer outcome after delayed start of treatment at more than eight weeks of age compared with a start at eight or less weeks of age. Interestingly, the development of the hips seems to be independent of the initial ultrasound hip type. Regular radiograph controls of all hip types seem to be justified to detect residual dysplasia.
Open access
This article is distributed under the terms of the Creative Commons Attribution-Non Commercial 4.0 International (CC BY-NC 4.0) licence (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed.
Compliance with ethical standards
Funding statement
No benefits in any form have been received or will be received from a commercial party related directly or indirectly to the subject of this article.
Ethical statement
Ethical approval: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards (Ethics committee vote of the local University, study no. 4949).
Informed Consent: Not required for this type of study.
ICMJE Conflict of interest statement
All author declare that they have no conflict of interest.
1. Graf R ed. Sonographie der Säuglingshüfte und therapeutische Konsequenzen: Ein Kompendium. [Internet]. 5th ed. Stuttgart: Georg Thieme Verlag 2000.
2. Tönnis D. Die angeborene Hüftdysplasie und Hüftluxation im Kindes- und Erwachsenenalter: Grundlagen Diagnostik konservative und operative Behandlung. Berlin Heidelberg: Springer-Verlag 2013.
3. Tschauner C Klapsch W Graf R. The effect of ultrasonography screening of hips in newborn infants on femur head necrosis and the rate of surgical interventions. Orthopade 1993;22:268–276.
4. Roper A. Hip dysplasia in the African Bantu. J Bone Joint Surg [Br] 1976;58-B:155–158.
5. Schwend RM Shaw BA Segal LS. Evaluation and treatment of developmental hip dysplasia in the newborn and infant. Pediatr Clin North Am 2014;61:1095–1107.
6. Al-Essa RS Aljahdali FH Alkhilaiwi RM et al.. Diagnosis and treatment of developmental dysplasia of the hip: A current practice of paediatric orthopaedic surgeons. J Orthop Surg (Hong Kong) 2017;25:2309499017717197.
7. de Hundt M Vlemmix F Bais JMJ et al.. Risk factors for developmental dysplasia of the hip: a meta-analysis. Eur J Obstet Gynecol Reprod Biol 2012;165:8–17.
8. Vafaee AR Baghdadi T Baghdadi A Jamnani RK. DDH epidemiology revisited: do we need new strategies? Arch Bone Jt Surg 2017;5:440–442.
9. Feldman G Dalsey C Fertala K et al.. The Otto Aufranc Award: identification of a 4 Mb region on chromosome 17q21 linked to developmental dysplasia of the hip in one 18-member multigeneration family. Clin Orthop Relat Res 2010;468:337–344.
10. Farr S Grill F Müller D. When is the optimal time for hip ultrasound screening? Orthopade 2008;37:532–540.
11. Grill F Müller D. Results of hip ultrasonographic screening in Austria. Orthopade 1997;26:25–32.
12. Wientroub S Grill F. Ultrasonography in developmental dysplasia of the hip. J Bone Joint Surg [Am] 2000;82-A:1004–1018.
13. Graf R. Advantages and disadvantages of various access routes in sonographic diagnosis of dysplasia and luxation in the infant hip. J Pediatr Orthop B 1997;6:248–252.
14. Bernau A. The Tübingen hip flexion splint in the treatment of hip dysplasia. Z Orthop Ihre Grenzgeb 1990;128:432–435.
15. Fettweis E. Sit-crouch-position-plaster in hip joint dysplasies. Arch Orthop Unfallchir 1968;63:38–51.
16. Bian Z Guo Y Tian W. Treatment of developmental dysplasia of the hip in children: results of closed reduction and immobilization in hip spica cast. Zhonghua Wai Ke Za Zhi 2009;47:1017–1019.
17. Pavlik A. Method of functional therapy with strap braces as a principle of conservative therapy of congenital dislocation of the hip in infants. Z Orthop Ihre Grenzgeb. 1957;89:341–352.
18. Wahlen R Zambelli P-Y. Treatment of the developmental dysplasia of the hip with an abduction brace in children up to 6 months old. Adv Orthop 2015;2015:103580.
19. Kubo H Pilge H Weimann-Stahlschmidt K et al.. Use of the Tübingen splint for the initial management of severely dysplastic and unstable hips in newborns with DDH: an alternative to Fettweis plaster and Pavlik harness. Arch Orthop Trauma Surg 2017;138:149–153.
20. Seidl T Lohmaier J Hölker T et al.. Reduction of unstable and dislocated hips applying the Tübingen hip flexion splint?. Orthopade 2012;41:195–199.
21. Burian M Dungl P Chomiak J Ošťádal M Frydrychová M. Efficiency of conservative treatment by overhead traction in developmental dysplasia of the hip. Acta Chir Orthop Traumatol Cech 2010;77:371–377.
22. Rosenbaum DG Servaes S Bogner EA Jaramillo D Mintz DN. MR Imaging in postreduction assessment of developmental dysplasia of the hip: goals and obstacles. Radiographics 2016;36:840–854.
23. Starr V Ha BY. Imaging update on developmental dysplasia of the hip with the role of MRI. AJR Am J Roentgenol 2014;203:1324–1335.
24. Sarkissian EJ Sankar WN Zhu X Wu CH Flynn JM. Radiographic follow-up of DDH in infants: are x-rays necessary after a normalized ultrasound? J Pediatr Orthop 2015;35:551–555.
25. Dornacher D Cakir B Reichel H Nelitz M. Early radiological outcome of ultrasound monitoring in infants with developmental dysplasia of the hips. J Pediatr Orthop B 2010;19:27–31.
26. Tönnis D. Radiography and arthrography in the infant hip. Orthopade 1997;26:49–58.
27. Miao M Cai H Hu L Wang Z. Retrospective observational study comparing the international hip dysplasia institute classification with the Tonnis classification of developmental dysplasia of the hip. Medicine (Baltimore) 2017;96:e5902.
28. Kalamchi A MacEwen GD. Avascular necrosis following treatment of congenital dislocation of the hip. J Bone Joint Surg [Am] 1980;62:876–888.
29. Graf R. Hip sonography: background; technique and common mistakes; results; debate and politics; challenges. Hip Int 2017;27:215–219.
30. Shorter D Hong T Osborn DA. Screening programmes for developmental dysplasia of the hip in newborn infants. Cochrane Database Syst Rev 2011;9:CD004595.
31. Patel H; Canadian Task Force on Preventive Health Care. Preventive health care 2001 update: screening and management of developmental dysplasia of the hip in newborns. CMAJ 2001;164:1669–1677.
32. Paton RW. Screening in developmental dysplasia of the hip (DDH). Surgeon 2017;15:290–296.
33. Sankar WN Nduaguba A Flynn JM. Ilfeld abduction orthosis is an effective second-line treatment after failure of Pavlik harness for infants with developmental dysplasia of the hip. J Bone Joint Surg [Am] 2015;97:292–297.
34. Novais EN Sanders J Kestel LA Carry PM Meyers ML. Graf Type-IV hips have a higher risk of residual acetabular dysplasia at 1 year of age following successful Pavlik harness treatment for developmental hip dysplasia. J Pediatr Orthop 2016;1.
35. Novais EN Kestel LA Carry PM Meyers ML. Higher Pavlik harness treatment failure is seen in Graf Type IV Ortolani-positive hips in males. Clin Orthop Relat Res 2016;474:1847–1854.
36. Schrading S Schulze A. Preoperative diagnostic imaging and planning. Orthopade 2016;45:644–652.
37. Kubo H Pilge H Nepp K Westhoff B Krauspe R. Development of unstable hips after treatment with the Tübingen splint: mid-term follow-up of 83 hip joints. Arch Orthop Trauma Surg 2018;138:629–634.
38. Allington NJ. Successful Pavlik harness treatment for developmental dysplasia of the hip and normal x-ray at the age of 2 years: is a longer follow-up necessary? J Pediatr Orthop 2015;37:328–331.
39. Cashman JP Round J Taylor G Clarke NMP. The natural history of developmental dysplasia of the hip after early supervised treatment in the Pavlik harness. A prospective longitudinal follow-up. J Bone Joint Surg [Br] 2002;84-B:418–425.
40. Smith BG Kasser JR Hey LA Jaramillo D Millis MB. Postreduction computed tomography in developmental dislocation of the hip: part I: analysis of measurement reliability. J Pediatr Orthop 1997;17:626–630.
41. Eberhardt O Zieger M Langendoerfer M Wirth T Fernandez FF. Determination of hip reduction in spica cast treatment for DDH: a comparison of radiography and ultrasound. J Child Orthop 2009;3:313–318.
42. Naumann T Zahniel K. Comparing the rate of femoral head necrosis of two different treatments of congenital dislocation of the hip. J Pediatr Orthop 1990;10:780–785.
43. Schur MD Lee C Arkader A Catalano A Choi PD. Risk factors for avascular necrosis after closed reduction for developmental dysplasia of the hip. J Child Orthop 2016;10:185–192.
44. van der Sluijs JA De Gier L Verbeke JI et al.. Prolonged treatment with the Pavlik harness in infants with developmental dysplasia of the hip. J Bone Joint Surg [Br] 2009;91-B:1090–1093.
45. Tucci JJ Kumar SJ Guille JT Rubbo ER. Late acetabular dysplasia following early successful Pavlik harness treatment of congenital dislocation of the hip. J Pediatr Orthop 1991;11:502–505.
H. Kubo
aCorrespondence should be sent to H. Kubo, University of Düsseldorf, Medical Faculty, Department of Orthopaedics, Moorenstr. 5, D-40225 Düsseldorf, Germany.
University of Düsseldorf, Medical Faculty, Department of Orthopaedics, Moorenstr. 5, D-40225 Düsseldorf, Germany
H. Pilge
University of Düsseldorf, Medical Faculty, Department of Orthopaedics, Moorenstr. 5, D-40225 Düsseldorf, Germany
J.-P. Holthoff
University of Düsseldorf, Medical Faculty, Department of Orthopaedics, Moorenstr. 5, D-40225 Düsseldorf, Germany
M. Hufeland
University of Düsseldorf, Medical Faculty, Department of Orthopaedics, Moorenstr. 5, D-40225 Düsseldorf, Germany
B. Westhoff
University of Düsseldorf, Medical Faculty, Department of Orthopaedics, Moorenstr. 5, D-40225 Düsseldorf, Germany
R. Krauspe
University of Düsseldorf, Medical Faculty, Department of Orthopaedics, Moorenstr. 5, D-40225 Düsseldorf, Germany
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
© 2018. This work is published under https://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Abstract
Purpose
In this study the course of unstable hips after successful treatment with Fettweis plaster of Paris (POP) is examined. Special focus will be given to age at beginning of treatment and initial hip type.
Methods
The development of 93 unstable hips treated between November 2001 and April 2015 was examined. Inclusion criteria were: 1) unstable hips with successful treatment with Fettweis POP; 2) presence of two pelvic radiographs (12 to 24 months and 24 to 48 months). We analyzed: 1) the initial ultrasound hip type according to Graf; 2) the average age at first and second radiograph; 3) the Tönnis classification: normal findings (< 1 SD), slightly (1 SD to 2 SD) and severely dysplastic hips (> 2 SD).
Results
In all, there were 14 hips type D, 41 hips type III and 38 hips type IV. Mean age of the first radiograph was 13.9 months and of the second 28.5 months. The first radiograph showed: (< 1 SD): 36, (1 SD to 2 SD): 34, (> 2 SD): 23 hips, the second radiograph: (< 1 SD): 33, (1 SD to 2 SD): 19, (> 2 SD): 30 hips. With subdivision at the start of treatment at age eight or fewer weeks 2/16 hips (12.5%) and with initiation of the treatment more than eight weeks 22/77 (26.0%) deteriorated. During the course between first and second radiograph a total of 35.7% of initial hip type D, 19.5% of type III and 23.7% of type IV deteriorated.
Conclusion
Radiograph controls after treatment with Fettweis POP show poorer outcome after delaying the start of treatment more than 8 weeks. These findings were independent of the initial ultrasound hip type. Regular radiograph controls of all hip types treated for unstable hips are justified to detect residual dysplasia.
Level of evidence:
IV
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer